AVENUE THERAPEUTICS, INC. - ATXI

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2024 · Q4 2023
Value (USD)
Total reported value ($000)
$33K
QoQ value delta ($000)
-$5K (-13.16%)
Implied price effect (QoQ)
-11.91%
Shares
Total shares
255,663
QoQ shares delta
-3,665 (-1.41%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ATXI)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2024)

Top 25 only Full list
Early Q4 2024 data: only 6 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10 71,947 0.0%
GEODE CAPITAL MANAGEMENT, LLC 7 52,160 0.0%
VANGUARD GROUP INC 6 46,293 0.0%
STATE STREET CORP 4 30,593 0.0%
JANE STREET GROUP, LLC 4 29,937 0.0%
MILLENNIUM MANAGEMENT LLC 1 10,501 0.0%
Tower Research Capital LLC (TRC) 1 8,872 0.0%
JPMORGAN CHASE & CO 0 5 0.0%
WELLS FARGO & COMPANY/MN 0 4,801 0.0%
ROYAL BANK OF CANADA 0 554 0.0%